Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-6966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells ; volume:12 ; number:1 ; day:6 ; month:2 ; year:2021 ; pages:1-20 ; date:12.2021
Cancer nanotechnology ; 12, Heft 1 (6.2.2021), 1-20, 12.2021
- Creator
-
Poonaki, Elham
Ariakia, Fatemeh
Jalili-Nik, Mohammad
Shafiee Ardestani, Mehdi
Tondro, Gholamhossein
Samini, Fariborz
Ghasemi, Sepideh
Sahab-Negah, Sajad
Gorji, Ali
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12645-021-00078-8
- URN
-
urn:nbn:de:101:1-2021042818450267003303
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Poonaki, Elham
- Ariakia, Fatemeh
- Jalili-Nik, Mohammad
- Shafiee Ardestani, Mehdi
- Tondro, Gholamhossein
- Samini, Fariborz
- Ghasemi, Sepideh
- Sahab-Negah, Sajad
- Gorji, Ali
- SpringerLink (Online service)
Other Objects (12)
Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells
PEG–PLGA nanoparticles for encapsulating ciprofloxacin
An ellagitannin-loaded CS-PEG decorated PLGA nano-prototype promotes cell cycle arrest in colorectal cancer cells
Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA
PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells
SN38-PEG-PLGA-verapamil nanoparticles inhibit proliferation and downregulate drug transporter ABCG2 gene expression in colorectal cancer cells
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations
PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs
Aptamer-labeled PLGA nanoparticles for targeting cancer cells
Attenuation of skin injury by a MARCO targeting PLGA nanoparticle
Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells
PEG–PLGA nanoparticles for encapsulating ciprofloxacin
An ellagitannin-loaded CS-PEG decorated PLGA nano-prototype promotes cell cycle arrest in colorectal cancer cells
Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA
PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells
SN38-PEG-PLGA-verapamil nanoparticles inhibit proliferation and downregulate drug transporter ABCG2 gene expression in colorectal cancer cells
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations
PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs
Aptamer-labeled PLGA nanoparticles for targeting cancer cells
Attenuation of skin injury by a MARCO targeting PLGA nanoparticle
Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells
PEG–PLGA nanoparticles for encapsulating ciprofloxacin
An ellagitannin-loaded CS-PEG decorated PLGA nano-prototype promotes cell cycle arrest in colorectal cancer cells
Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA
PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells
SN38-PEG-PLGA-verapamil nanoparticles inhibit proliferation and downregulate drug transporter ABCG2 gene expression in colorectal cancer cells
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations
PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs
Aptamer-labeled PLGA nanoparticles for targeting cancer cells